| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.846 | 17.833 | 0 | 0 | 0 | 6.422 | 8.927 | 5.339 | 71 | 385 |
| Total Income - EUR | 12.846 | 17.833 | 0 | 0 | 0 | 6.422 | 8.972 | 5.347 | 71 | 396 |
| Total Expenses - EUR | 2.139 | 7.389 | 2.852 | 471 | 160 | 5.830 | 3.572 | 4.907 | 4.477 | 233 |
| Gross Profit/Loss - EUR | 10.707 | 10.444 | -2.852 | -471 | -160 | 593 | 5.400 | 441 | -4.406 | 163 |
| Net Profit/Loss - EUR | 10.322 | 9.909 | -2.852 | -471 | -160 | 400 | 5.131 | 280 | -4.406 | 139 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Almamed Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 139 | 138 | 136 | 133 | 131 | 128 | 125 | 126 | 125 | 125 |
| Current Assets | 7.356 | 15.824 | 10.450 | 8.019 | 7.704 | 5.347 | 10.005 | 10.854 | 6.236 | 6.499 |
| Inventories | 4.342 | 5.557 | 5.463 | 4.112 | 4.033 | 2.108 | 7.713 | 8.446 | 4.542 | 4.517 |
| Receivables | 910 | 1.964 | 64 | 125 | 145 | 0 | 37 | 0 | 0 | 362 |
| Cash | 2.104 | 8.303 | 4.923 | 3.782 | 3.526 | 3.240 | 2.255 | 2.409 | 1.694 | 1.621 |
| Shareholders Funds | 6.128 | 9.954 | -2.809 | -3.228 | -3.326 | -2.627 | 2.561 | 2.850 | 405 | 541 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.368 | 6.009 | 13.395 | 11.381 | 11.160 | 8.103 | 7.569 | 8.130 | 5.956 | 6.083 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4639 - 4639" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Almamed Plus S.r.l.